Allogene

AACR 2023 – Moderna's immunotherapeutic splash
EP Vantage
Wed, 03/22/23 - 10:03 am
AACR
Moderna Therapeutics
Allogene
AstraZeneca
Merck
Roche
Novartis
Eli Lilly
Innovent
Springworks
Biogene
Relay Therapeutics
Vivace Therapeutics
Allogene Therapeutics Initiates Industry’s First Allogeneic CAR T Phase 2 Trial
Global Newswire
Thu, 10/6/22 - 07:06 pm
Allogene
large B cell lymphoma
clinical trials
ALLO-501a
CAR-T
As biotech retreats, gene therapy companies retrench and redraw plans
BioPharma Dive
Thu, 03/24/22 - 08:29 pm
biotech
gene therapy
layoffs
R&D
Bluebird Bio
Allogene
uniQure
A late Christmas present for Allogene
EP Vantage
Mon, 01/10/22 - 11:27 am
Allogene
JPMHC 2022
FDA
CAR-T
10 clinical trials to watch in the first half of 2022
BioPharma Dive
Mon, 01/3/22 - 10:46 am
clinical trials
Pfizer
Arena Pharmaceuticals
etrasimod
Sanofi
GSK
vaccines
COVID-19
Roche
gantenerumab
AbbVie
Gilead Sciences
Trodelvy
Karuna Therapeutics
KarXT
Intercept Pharma
obeticholic acid
Allogene
ALLO-501a
Off-the-shelf CAR-T, a Tagrisso rival and the next breast cancer drugs: a look ahead at ASCO
BioPharma Dive
Thu, 05/20/21 - 11:18 pm
ASCO 2021
Allogene
CAR-T
Bristol Myers Squibb
EQRx
Allogene, broadening its reach, helps start a new biotech in China
BioPharma Dive
Tue, 12/15/20 - 10:47 am
Allogene
Overland Pharmaceuticals
China
cell therapies
Allogene Overland Pharma
ASH: Allogene's off-the-shelf CAR-T posts 60% response rate in fiercely competitive BCMA field
Fierce Biotech
Mon, 12/7/20 - 10:48 am
ASH2020
Allogene
CAR-T
Asco 2020 movers – cell therapy companies dominate the risers
EP Vantage
Thu, 06/4/20 - 10:56 am
ASCO 2020
cell therapy
Adaptimmune
Allogene
Iovance
Allogene’s ALLO-501 Shows Positive Results in Its Phase I ALPHA Trial
BioSpace
Sat, 05/30/20 - 07:50 pm
Allogene
ASCO 2020
ALLO-501
clinical trials
refractory indolent non-Hodgkins lymphoma
ASCO: Allogene reports 63% response rate in early trial of off-the-shelf CAR-T in lymphoma
Fierce Biotech
Fri, 05/29/20 - 10:57 am
Allogene
ASCO 2020
CAR-T
ALLO-501
ALLO-647
lymphoma
Allogene gives first look at an 'off the shelf' cell therapy for lymphoma
BioPharma Dive
Wed, 05/13/20 - 10:35 pm
Allogene
ASCO 2020
cell therapy
non-Hodgkin lymphoma
ALLO-501
ALLO-647
Two biotech CEOs test positive for Covid-19 after attending investor conference
MedCity News
Mon, 03/16/20 - 10:59 am
Pharma CEOs
Allogene
Apellis Pharmaceuticals
Arie Belldegrun
Cedric Francois
COVID-19
Biogen
Allogene, SpringWorks to Test Drug Combo in Multiple Myeloma Trial
Xconomy
Mon, 01/13/20 - 10:25 am
SpringWorks Therapeutics
Allogene
Multiple Myeloma
clinical trials
ALLO-715
nirogacestat
A Record Year: A Look at the Biotech IPOs for Q4 2018
BioSpace
Fri, 12/28/18 - 12:57 pm
IPOs
biotech
Moderna Therapeutics
Allogene
Rubius Therapeutics
Kodiak Sciences
Guardant Health
SI Bone
#ASH18: Allogene ticks off a high CR rate for updated off-the-shelf CAR-T pioneer. But getting just the right kind of immunosuppression is crucial
Endpoints
Mon, 12/3/18 - 10:50 pm
ASH 2018
Allogene
CAR-T
ALL
Allogene raises $324M in year's largest biotech IPO on NASDAQ
BioCentury
Wed, 10/10/18 - 10:56 pm
Allogene
IPOs
cell therapy
NASDAQ
Allogene IPO could be year's largest biotech listing on NASDAQ
BioCentury
Tue, 10/2/18 - 07:45 pm
IPOs
NASDAQ
Allogene
CAR-T
Allogene Therapeutics Announces Filing For IPO
CP Wire
Fri, 09/14/18 - 09:39 am
Allogene
IPOs
CAR-T
Allogene Therapeutics Banks $120 Million in Private Financing
CP Wire
Thu, 09/6/18 - 09:50 am
Allogene
Gilead Sciences
Pfizer

Pages